Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | -10.00% | -35.71% | -59.09% |
Jun. 07 | Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD | CI |
May. 31 | Transcript : Numinus Wellness Inc. - Shareholder/Analyst Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.09% | 11.65M | |
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |
- Stock Market
- Equities
- NUMI Stock
- News Numinus Wellness Inc.
- Numinus Wellness to Focus on U.S. Operations as it Transitions Out of Canada